GO
Loading...

Allergan Inc

More

  • Midday Glance: Medical Devices companies Tuesday, 9 Dec 2014 | 1:21 PM ET

    Allergan fell$. 94 or. 4 percent, to $211.62. Baxter International Inc. fell$. 74 or 1.0 percent, to $73.38. Boston Scientific Corp. rose$. 05 or. 4 percent, to $12.99.

  • Early Glance: Medical Devices companies Tuesday, 9 Dec 2014 | 10:21 AM ET

    Allergan fell $1.07 or. 5 percent, to $211.49. Baxter International Inc. fell$. 61 or. 8 percent, to $73.51. Boston Scientific Corp. fell$. 05 or. 4 percent, to $12.89.

  • NEW YORK/ WINNIPEG, Dec 9- Valeant Pharmaceuticals International Inc is abandoning its growth-by-acquisitions strategy for the time being to try to reduce debt, boost its stock price and one day return to its traditional deal-making in a stronger position, people familiar with the matter told Reuters. Speculation about Valeant's next takeover target has...

  • NEW YORK/ WINNIPEG, Dec 9- Valeant Pharmaceuticals International Inc is abandoning its growth-by-acquisitions strategy for the time being to try to reduce debt, boost its stock price and one day return to its traditional deal-making in a stronger position, people familiar with the matter told Reuters. Speculation about Valeant's next takeover target has...

  • Final Glance: Medical Devices companies Monday, 8 Dec 2014 | 6:02 PM ET

    Allergan fell$. 79 or. 4 percent, to $212.56. Baxter International Inc. fell$. 10 or. 1 percent, to $74.12. Boston Scientific Corp. rose$. 03 or. 2 percent, to $12.94.

  • Midday Glance: Medical Devices companies Monday, 8 Dec 2014 | 1:20 PM ET

    Allergan fell$. 15 or. 1 percent, to $213.20. Baxter International Inc. fell$. 01 or percent, to $74.21. Medtronic fell$. 03 or percent, to $75.01.

  • Early Glance: Medical Devices companies Monday, 8 Dec 2014 | 10:22 AM ET

    Allergan rose$. 39 or. 2 percent, to $213.74. Baxter International Inc. rose$. 13 or. 2 percent, to $74.35. Boston Scientific Corp. rose$. 01 or. 1 percent, to $12.92.

  • Final Glance: Medical Devices companies Friday, 5 Dec 2014 | 6:02 PM ET

    Allergan fell$. 36 or. 2 percent, to $213.35. Baxter International Inc. rose$. 65 or. 9 percent, to $74.22. Boston Scientific Corp. rose$. 13 or 1.0 percent, to $12.91.

  • Midday Glance: Medical Devices companies Friday, 5 Dec 2014 | 1:17 PM ET

    Allergan rose$. 21 or. 1 percent, to $213.92. Baxter International Inc. rose$. 61 or. 8 percent, to $74.18. Boston Scientific Corp. rose$. 08 or. 6 percent, to $12.86.

  • Early Glance: Medical Devices companies Friday, 5 Dec 2014 | 10:27 AM ET

    Allergan rose$. 89 or. 4 percent, to $214.60. Baxter International Inc. rose$. 18 or. 2 percent, to $73.75. Boston Scientific Corp. rose$. 06 or. 5 percent, to $12.84.

  • BOSTON, Nov 26- Hedge fund mogul William Ackman told investors they could see a $6 billion payday when he closes the chapter on Allergan Inc., his firm's biggest bet of 2014.. One week after Allergan agreed to sell itself to rival Actavis Plc., Ackman wrote in his quarterly investment letter that his Pershing Square Capital Management, the Botox-maker's biggest...

  • *RenaissanceRe to buy Platinum for $1.9 bln. NEW YORK, Nov 24- U.S. stock index futures pointed to a higher open on Monday, indicating that major indexes would move further into record territory on the back of multiple merger deals and hopes that China will take further accommodative monetary policy action. Equities closed a fifth straight week of advances Friday,...

  • US STOCKS-Futures rise, boosted by merger activity Monday, 24 Nov 2014 | 8:14 AM ET

    *RenaissanceRe to buy Platinum for $1.9 bln. NEW YORK, Nov 24- U.S. stock index futures rose on Monday, indicating that major indexes would move further into record territory, on the back of multiple merger deals and hopes that China will take further accommodative monetary policy action. Equities closed a fifth straight week of advances Friday, with the Dow and S&P...

  • Goldman Sachs Group Inc retained its No. 1 position as M&A adviser with deals worth $877 billion, followed by JPMorgan Chase& Co with $651 billion and Citigroup Inc with $633 billion. The $66.4 billion bid for Allergan Inc by Actavis PLC this week more than doubled the total value of deals in the healthcare sector to $364 billion. Halliburton Co's plans to buy...

  • Valeant slashes stake in Allergan after losing bid Thursday, 20 Nov 2014 | 7:14 PM ET

    Nov 20- Valeant Pharmaceuticals International Inc said it cut its stake in Allergan Inc to 0.1 percent from 9.7 percent, three days after Actavis Plc trumped its offer for the Botox maker. Pershing Square Capital Management informed Valeant that PS Fund 1 sold all of its 2.2 million shares in Allergan allocated to Valeant USA, Valeant said in a regulatory filing.

  • Nov 20- Canada's Valeant Pharmaceuticals International Inc said it may buy back up to $2 billion worth of securities, replacing a previous $1.5 billion program under which it bought back no securities. The announcement comes a few days after acquisition-hungry Valeant's $54 billion offer to buy Botox maker Allergan Inc was trumped by Actavis Plc's $66...

  • Cramer plays oil merger matchmaker Wednesday, 19 Nov 2014 | 6:55 PM ET

    Jim Cramer is feeling inspired by mergers announced recently and thinks these two large players in the oil patch should get hitched.

  • Stocks little moved after Fed; Nasdaq ends lower Wednesday, 19 Nov 2014 | 4:45 PM ET
    Trader on the floor of the New York Stock Exchange.

    Stocks fell on Wednesday, as investors waited for minutes from the Fed.

  • Asian indices mixed on Japan woes; FOMC minutes eyed Wednesday, 19 Nov 2014 | 2:10 AM ET
    Pedestrians pass before a share prices board in Tokyo on November 17, 2014. Japan's share prices fell 453.18 points to close at 17,037.65 points at the morning session of the Tokyo Stock Exchange, after official data showed Japan's economy surprisingly slumped into a recession.

    Trading was mixed in Asia on Wednesday, as sentiment turned cautious amid concerns over the health of Japan - the world's third largest economy - and ahead of the release of the U.S. Federal Reserves' meeting minutes.

  • *Nikkei erases gains, Asia shares hit by weak commodity prices. TOKYO, Nov 19- Japanese shares gave up early gains on Wednesday as investors booked profits after Prime Minister Shinzo Abe delayed a tax hike and said he would call a snap election to seek a fresh mandate for his economic policies. Japan's Nikkei erased earlier gains to stand flat by midday, showing...